Press Releases Latest Jun 02, 2023 Theratechnologies Receives FDA Agreement to Amended Trial Protocol for its Lead PDC Candidate Sudocetaxel Zendusortide Press Releases Year None20232022202120202019201820172016201520142013 Oct 13, 2021 Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2021 and Provides Business Update Oct 06, 2021 Theratechnologies to Present at the H.C. Wainwright 5th Annual Nash Investor Conference Sep 29, 2021 Theratechnologies to Announce Financial Results for Its Third Quarter Fiscal 2021 Sep 22, 2021 Theratechnologies Announces Positive Results for Trogarzo® IV Push Administration Study Sep 16, 2021 Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29, 2021 Sep 07, 2021 Theratechnologies to Present at the H.C. Wainwright 23rd Annual Global Investment Conference Sep 01, 2021 Theratechnologies to Host Key Opinion Leader Event to Discuss Tesamorelin for the Treatment of Non-Alcoholic Steatohepatitis (NASH) Aug 13, 2021 Theratechnologies Announces Publication of TH1902 Preclinical Data in Peer-Reviewed Journal, Cancer Science Aug 04, 2021 Theratechnologies to Present at the Canaccord Genuity 41st Annual Growth Conference Jul 23, 2021 Theratechnologies Establishes New At-The-Market Facility First page « Previous page ‹ … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page › Last page » Displaying 51 - 60 of 312
Jun 02, 2023 Theratechnologies Receives FDA Agreement to Amended Trial Protocol for its Lead PDC Candidate Sudocetaxel Zendusortide
Oct 13, 2021 Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2021 and Provides Business Update
Sep 16, 2021 Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29, 2021
Sep 07, 2021 Theratechnologies to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Sep 01, 2021 Theratechnologies to Host Key Opinion Leader Event to Discuss Tesamorelin for the Treatment of Non-Alcoholic Steatohepatitis (NASH)
Aug 13, 2021 Theratechnologies Announces Publication of TH1902 Preclinical Data in Peer-Reviewed Journal, Cancer Science
